scispace - formally typeset
N

Naoya Fujita

Researcher at Japanese Foundation for Cancer Research

Publications -  159
Citations -  12199

Naoya Fujita is an academic researcher from Japanese Foundation for Cancer Research. The author has contributed to research in topics: Cancer & Protein kinase B. The author has an hindex of 58, co-authored 146 publications receiving 11096 citations. Previous affiliations of Naoya Fujita include Pharmaceuticals and Medical Devices Agency & Meiji Pharmaceutical University.

Papers
More filters
Journal ArticleDOI

Modulation of Akt kinase activity by binding to Hsp90

TL;DR: Results indicate that Hsp90 plays an important role in maintaining Akt kinase activity by preventing PP2A-mediated dephosphorylation.
Journal ArticleDOI

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.

TL;DR: In this article, a review on molecular cancer therapeutics, including molecular mechanisms and therapeutic approaches, is presented, focusing on the areas of drug resistance, apoptosis and apoptosis resistance, and survival-signaling.
Journal ArticleDOI

Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow

TL;DR: It is demonstrated that Rap1 plays a pivotal role in chemokine-induced integrin activation and migration and induced a polarized morphology, accompanied by the redistribution of CXCR4 and CD44 to the leading edge and uropod, respectively.
Journal ArticleDOI

Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.

TL;DR: Akt promotes cell-cycle progression through the mechanisms of phosphorylation-dependent 14-3-3 binding to p27Kip1 and cytoplasmic localization and the COOH-terminal Thr198 residue as a novel site.